Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.

ctDNA in neoadjuvant-treated breast cancer was studied as a reflection of treatment response and survival. The abstract does not name a commercial assay.

Annals of OncologyPubMed 33232761DOI 10.1016/j.annonc.2020.11.007